Title: | STAP‐2 negatively regulates BCR‐mediated B cell activation by recruiting tyrosine‐protein kinase CSK to LYN |
Authors: | Kashiwakura, Jun‐ichi Browse this author |
Kawahara, Shoya Browse this author |
Inagaki, Iori Browse this author |
Inui, Kyosuke Browse this author |
Saitoh, Kodai Browse this author |
Kagohashi, Kota Browse this author |
Sasaki, Yuto Browse this author |
Kobayashi, Fuki Browse this author |
Kitai, Yuichi Browse this author →KAKEN DB |
Muromoto, Ryuta Browse this author →KAKEN DB |
Oritani, Kenji Browse this author →KAKEN DB |
Matsuda, Tadashi Browse this author →KAKEN DB |
Keywords: | B cells |
Csk |
Lyn |
signal-transducing adaptor protein-2 |
Issue Date: | 5-Sep-2023 |
Publisher: | WILEY |
Journal Title: | FEBS Letters |
Volume: | 597 |
Issue: | 19 |
Start Page: | 2433 |
End Page: | 2445 |
Publisher DOI: | 10.1002/1873-3468.14730 |
PMID: | 37669828 |
Abstract: | Although signal-transducing adaptor protein-2 (STAP-2) acts in certain immune responses, its role in B cell receptor (BCR)-mediated signals remains unknown. In this study, we have revealed that BCR-mediated signals, cytokine production and antibody production were increased in STAP-2 knockout (KO) mice compared with wild-type (WT) mice. Phosphorylation of tyrosine-protein kinase LYN Y508 was reduced in STAP-2 KO B cells after BCR stimulation. Mechanistic analysis revealed that STAP-2 directly binds to LYN, dependently of STAP-2 Y250 phosphorylation by LYN. Furthermore, phosphorylation of STAP-2 enhanced interactions between LYN and tyrosine-protein kinase CSK, resulting in enhanced CSK-mediated LYN Y508 phosphorylation. These results suggest that STAP-2 is crucial for controlling BCR-mediated signals and antibody production by enhanced CSK-mediated feedback regulation of LYN. |
Rights: | This is the peer reviewed version of the following article: https://febs.onlinelibrary.wiley.com/doi/10.1002/1873-3468.14730, which has been published in final form at 10.1002/1873-3468.14730. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions. This article may not be enhanced, enriched or otherwise transformed into a derivative work, without express permission from Wiley or by statutory rights under applicable legislation. Copyright notices must not be removed, obscured or modified. The article must be linked to Wiley’s version of record on Wiley Online Library and any embedding, framing or otherwise making available the article or pages thereof by third parties from platforms, services and websites other than Wiley Online Library must be prohibited. |
Type: | article (author version) |
URI: | http://hdl.handle.net/2115/93039 |
Appears in Collections: | 薬学研究院 (Faculty of Pharmaceutical Sciences) > 雑誌発表論文等 (Peer-reviewed Journal Articles, etc)
|